Vaginal immunization to elicit Primary T-cell activation and dissemination

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Pettini, Elena ^a   Prota, Gennaro ^a   Ciabattini, Annalisa ^a   Boianelli, Alessandro ^a   Fiorino, Fabio ^a   Pozzi, Gianni ^a   Vicino, Antonio ^a   Medaglini, Donata ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RB ANTIGEN; CD69 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; HERMES ANTIGEN; L SELECTIN; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL EXPANSION; CELL HOMING; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNIZATION; IN VITRO STUDY; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN; VACCINATION; VAGINA;

EID: 84891920129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080545     Document Type: Article

References (56)

1. Harandi AM, Medaglini D (2010) Mucosal Adjuvants. Curr HIV Res 8:330-335.
2. Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nature Medicine 11:45-53.
3. Holmgren J, Svennerholm AM (2012) Vaccines against mucosal infections. Curr Opin Immunol 24:343-353.
4. Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12:592-605.
5. Pavot V, Rochereau N, Genin C, Verrier B, Paul S (2012) New insights in mucosal vaccine development. Vaccine 30:142-154.
6. Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, et al. (2012) Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 11:367-379.
7. Mann JFS, McKay OF, Arokiasamy S, Patel RK, Tregoning JS, et al. (2013) Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice. PLoS ONE 8:e67412.
8. Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148-158. (Pubitemid 43361590)
9. Brandtzaeg P, Pabst R (2005) Let's go mucosal: communication on slippery ground. Trends Immunol 25:570-577.
10. Brandtzaeg P (2011) Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med 183:1595-1604.
11. Lehner T (2009) Innate and adaptive mucosal immunity in protection against HIV infection. Adv Dent Res 19:21-28.
12. Gherardi MM, Najera JL, Perez-Jimenez E, Guerra S, Garcia-Sastre A, et al. (2003) Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. J Virol 77:7048-7057. (Pubitemid 36666898)
13. Mestecky J, Moldoveanu Z, Russell MW (2005) Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reproduct Immunol 53:208-214. (Pubitemid 40542802)
14. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206:306-335. (Pubitemid 41105178)
15. Wright PF (2011) Inductive/effector mechanisms for humoral immunity at mucosal sites. Am J Reprod Immunol 65:248-252.
16. Hickey DK, Fahey JV, Wira CR (2013) Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, alpha-/beta-defensins and TLRs. Innate Immun 19:121-131.
17. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, et al. (2010) Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 63:544-565.
18. Seavey MM, Mosmann TR (2009) Estradiol-induced vaginal mucus inhibits antigen penetration and CD8 (+) T cell priming in response to intravaginal immunization. Vaccine 27:2342-2349.
19. Marks EM, Helgeby A, Andersson JO, Schön K, Lycke NY (2011) CD4+ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. Eur J Immunol 41:2642-2653.
20. Hickey DK, Patel MV, Fahey JV, Wira CR (2011) Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88:185-194.
21. Wira CR, Rossoll RM, Kaushic C (2000) Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology 141:2877-2885. (Pubitemid 32250451)
22. Naz RK (2012) Female genital tract immunity: distinct immunological challenges for vaccine development. J Reprod Immunol 93:1-8.
23. Ciabattini A, Giomarelli B, Parigi R, Chiavolini D, Pettini E, et al. (2008) Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine 26:4244-4250.
24. Kiyono H, Fukuyama S (2004) NALT-versus Peyer's-Patch-mediated mucosal immunity. Nat Rev 4:699-710. (Pubitemid 39223076)
25. Zuercher AW (2003) Upper respiratory tract immunity. Viral Immunol 16:279-289. (Pubitemid 37229541)
26. Russel MW, Mestecky J (2002) Humoral immune responses to microbial infections in the genital tract. Microbes and Infection 4:667-677. (Pubitemid 34607416)
27. Fiorino F, Pettini E, Pozzi G, Medaglini D, Ciabattini A (2013) Prime-boost strategies in mucosal immunization affect local IgA production and the type of Th response. Front Immunol 4:1-8.
28. Del Campo J, Lindquist L, Cuello M, Backstrom M, Cabrerra O, et al. (2010) Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine 28:1193-1200.
29. Ciabattini A, Pettini E, Andersen P, Pozzi G, Medaglini D (2008) Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria. Infect Immun 76:5817-5825.
30. Medaglini D, Ciabattini A, Cuppone AM, Costa C, Ricci S, et al. (2006) In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii. Infect Immun 74:2760-2766. (Pubitemid 43672985)
31. Ciabattini A, Pettini E, Arsenijevic S, Pozzi G, Medaglini D (2010) Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ cells in the genital and intestinal tracts. Vaccine 28:1226-1233.
32. Ciabattini A, Pettini E, Fiorino F, Prota G, Pozzi G, et al. (2011) Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. PLoS ONE 6:e19346.
33. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, et al. (2007) Naive CD4 (+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213. (Pubitemid 47284919)
34. Kearney ER, Pape KA, Loh DY, Jenkins MK (1994) Visualization of peptidespecific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-339.
35. Pettini E, Ciabattini A, Pozzi G, Medaglini D (2009) Adoptive transfer of transgenic T cells to study mucosal adjuvants. Methods 49:340-345.
36. Hawkins ED, Turner ML, Dowling MR, van Gend C., Hodgkin PD (2007) A model of immune regulation as a consequence of randomized lymphocyte division and death times. Proc Natl Acad Sci U S A 104:5032-5037. (Pubitemid 47186171)
37. Harris TE (1964) The theory of branching process. Courier Dover Pubblications.
38. Yates A, Chan C, Strid J, Moon S, Callard R, et al. (2007) Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics 8.
39. Yakovlevi AY, Yanevi MN (2009) Relative frequencies in multitype branching processes. The annals of applied probability 19:1-14.
40. Hyrien O, Chen R, Zand MS (2010) An age-dependent branching process model for the analysis of CFSE-labeling experiments. Biol Direct 5:41.
41. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM (2011) CpG DNA as vaccine adjuvant. Exp Rev Vacc 10:499-511.
42. Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and betachain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34-40. (Pubitemid 28194695)
43. Lyons AB, Parish CR (1994) Determination of lymphocyte division by flow cytometry. J Immunol Methods 171:131-137. (Pubitemid 24140219)
44. Kimmel M, Axelros DE (2002) Branching processes in biology. Interdisciplinary Applied Mathematics.
45. Athreya KB, Ney PE (1972) Branching processes. Dover Book on Mathematics.
46. Quine MP (1970) The multi-type Galton-Watson process with immigration. Journal of Applied Probability 7:411-422.
47. Thompson BS, Mitchell TC (2004) Measurement of daughter cell accumulation during lymphocyte proliferation in vivo. J Immunol Methods 295:79-87. (Pubitemid 41057770)
48. Luci C, Hervouet C, Rousseau D, Holmgreen J, Czerkinsky C, et al. (2006) Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol 176:2749-2757.
49. Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, et al. (2002) Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 169:566-574. (Pubitemid 34686180)
50. Naz RK (2012) Female genital tract immunity: distinct immunological challenges for vaccine development. J Reprod Immunol 93:1-8.
51. Davis SS (2001) Nasal vaccines. Adv Drug Deliv Rev 51:21-42. (Pubitemid 32763070)
52. Wira CR, Crane-Godreau MA, Grant KS (2005) Endocrine regulation of the mucosal immune system in the female reproductive tract. In: Mestecky Jeal, editors. Mucosal Immunology. Amsterdam: Elsevier/Academic Press. pp. 1661-1676.
53. Sancho D, Gomez M, Sanchez F (2005) CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26:136-140. (Pubitemid 40312520)
54. Mitchell DM, Williams MA (2010) An activation marker finds a function. Immunity 32:9-11.
55. Lee WT, Yin X, Vitetta ES (1990) Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. J Immunol 144:3288-3295. (Pubitemid 20146356)
56. Warnock RA, Askari S, Butcher E, von Andrian UH (1998) Molecular mechanism of lymphocyte homing to peripheral lymph nodes. J Exp Med 187:20 16.